ANGOAngioDynamics, Inc.Healthcare · Medical - Instruments & Suppliesas of 2026-09-16
Horizon

Issued 2026-09-16 at $15.46 · now $15.46 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, ANGO has typically landed between $12.28 and $18.67 — a range of −20.6% to +20.7% from the issuance price $15.46.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($15.46) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where ANGO has typically landed a month from the 2026-09-16 close of $15.46 — the range is history, not a prediction.

$12.28worst · -20.6%$18.67best · +20.7%
  • now $15.46 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $15.45 (-0.0%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $14.03–$16.87
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $12.28–$18.67
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2008-02-07−48.2%−48.2%+0.0%
2008-02-06−46.7%−46.7%+2.3%
2008-02-08−45.1%−45.9%+3.3%
3 best
2024-12-06+84.9%+0.0%+84.9%
2024-12-19+45.1%+0.0%+50.8%
2024-12-24+44.0%+0.0%+48.9%

5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
45%
−0.7%
n=20
Feb
45%
−2.9%
n=20
Mar
40%
−4.1%
n=20
Apr
35%
−0.7%
n=20
May
40%
+0.6%
n=20
Jun
60%
+4.5%
n=20
Jul
50%
+1.2%
n=20
Aug
55%
+1.6%
n=20
Sep
50%
+1.1%
n=20
Oct
40%
−2.6%
n=20
Nov
50%
+1.1%
n=20
Dec
80%
+6.4%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$16$92026-07-30: 1 insider sale, $344K — Nighan Warren JR2025-10-21: 1 insider purchase, $118K — Weiss Lawrence T2025-10-13: 1 insider purchase, $10K — Trowbridge Stephen A2025-10-09: 1 insider purchase, $112K — Clemmer James C2025-10: 3 open-market purchases, $240K2026-07: 1 open-market sale, $344K↑ buys↓ salesofficer Nighan Warren JR — Sale on 2026-07-30, filed 1 day after the tradeofficer Weiss Lawrence T — Purchase on 2025-10-21, filed 1 day after the tradeofficer Trowbridge Stephen A — Purchase on 2025-10-13, filed 1 day after the tradedirector Clemmer James C — Purchase on 2025-10-09, filed same day
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-07-30Nighan Warren JRofficerSale23,370 @ $14.72$344K−26.5% of holding+3.6%not yet — horizon still open64,745Form 4 · filed 1 day after the trade
2025-10-21Weiss Lawrence TofficerPurchase10,000 @ $11.81$118K+12.0% of holding+3.0%−10.4%93,597Form 4 · filed 1 day after the trade
2025-10-13Trowbridge Stephen AofficerPurchase890 @ $11.16$10K+0.3% of holding+10.3%−13.3%256,629Form 4 · filed 1 day after the trade
2025-10-09Clemmer James CdirectorPurchase10,000 @ $11.15$112K+1.1% of holding+7.9%−10.9%882,529Form 4 · filed same day
2025-01-16Nighan Warren JRofficerSale4,060 @ $12.31$50K−8.8% of holding−21.7%−36.5%41,817Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

85 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-07-22Clemmer James CdirectorWithheld for tax26,728862,448Form 4
2026-07-22Trowbridge Stephen AofficerWithheld for tax8,319305,796Form 4
2026-07-22Piccinini LauraofficerWithheld for tax4,50681,929Form 4
2026-07-22Campbell Chad ThomasofficerWithheld for tax2,330108,676Form 4
2026-07-22Nighan Warren JRofficerWithheld for tax1,67188,115Form 4
2026-07-22Trowbridge Stephen AofficerOption exercise57,3810Form 4
2026-07-22Nighan Warren JRofficerOption exercise5,69489,786Form 4
2026-07-22Nighan Warren JRofficerOption exercise20,0520Form 4
2026-07-22Piccinini LauraofficerOption exercise28,3360Form 4
2026-07-22Piccinini LauraofficerOption exercise8,04786,435Form 4
2026-07-22Campbell Chad ThomasofficerOption exercise6,466111,006Form 4
2026-07-22Campbell Chad ThomasofficerOption exercise22,7680Form 4
2026-07-22Clemmer James CdirectorOption exercise52,358889,176Form 4
2026-07-22Clemmer James CdirectorOption exercise184,3610Form 4
2026-07-22Trowbridge Stephen AofficerOption exercise16,296314,115Form 4
2026-07-20Clemmer James CdirectorWithheld for tax4,223836,818Form 4
2026-07-20Trowbridge Stephen AofficerWithheld for tax717244,562Form 4
2026-07-20Piccinini LauraofficerWithheld for tax61658,528Form 4
2026-07-20Campbell Chad ThomasofficerWithheld for tax35988,459Form 4
2026-07-20Nighan Warren JRofficerWithheld for tax25166,126Form 4
2026-07-19Clemmer James CdirectorWithheld for tax11,764841,528Form 4
2026-07-19Clemmer James CdirectorWithheld for tax487841,041Form 4
2026-07-17Clemmer James CdirectorWithheld for tax10,649853,292Form 4
2026-07-17Trowbridge Stephen AofficerWithheld for tax3,510245,279Form 4
2026-07-17Piccinini LauraofficerWithheld for tax3,07459,144Form 4
2026-07-17Nighan Warren JRofficerWithheld for tax1,37366,377Form 4
2026-07-17Campbell Chad ThomasofficerWithheld for tax1,11288,818Form 4
2026-07-16Clemmer James CdirectorWithheld for tax18,588863,941Form 4
2026-07-16Trowbridge Stephen AofficerWithheld for tax7,840248,789Form 4
2026-07-16Piccinini LauraofficerWithheld for tax4,53862,218Form 4
2026-07-16Campbell Chad ThomasofficerWithheld for tax2,36789,930Form 4
2026-07-16Weiss Lawrence TofficerWithheld for tax2,26791,330Form 4
2026-07-16Nighan Warren JRofficerWithheld for tax2,15367,750Form 4
2026-07-15Tarnoff Michael EdirectorAward / grant11,88795,265Form 4
2026-07-15Trowbridge Stephen AofficerAward / grant53,25753,257Form 4
2026-07-15Trowbridge Stephen AofficerAward / grant53,257297,819Form 4
2026-07-15Piccinini LauraofficerAward / grant19,86019,860Form 4
2026-07-15Piccinini LauraofficerAward / grant19,86078,388Form 4
2026-07-15Nighan Warren JRofficerAward / grant17,96617,966Form 4
2026-07-15Nighan Warren JRofficerAward / grant17,96684,092Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.